These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15195513)

  • 1. Optimization of radioimmunotherapy interactions with hyperthermia.
    Kinuya S; Yokoyama K; Michigishi T; Tonami N
    Int J Hyperthermia; 2004 Mar; 20(2):190-200. PubMed ID: 15195513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia.
    Hauck ML; Zalutsky MR
    Int J Hyperthermia; 2005 Feb; 21(1):1-11. PubMed ID: 15764347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia. Part II: Application of the thermal equivalency equation.
    Hauck ML; Zalutsky MR
    Int J Hyperthermia; 2005 Feb; 21(1):13-27. PubMed ID: 15764348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal timing of administration of hyperthermia in combined radioimmunotherapy.
    Kinuya S; Yokoyama K; Hiramatsu T; Konishi S; Watanabe N; Shuke N; Aburano T; Bunko H; Michigishi T; Tonami N
    Cancer Biother Radiopharm; 2000 Aug; 15(4):373-9. PubMed ID: 11041022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
    Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
    Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity.
    Hanaoka H; Katagiri T; Fukukawa C; Yoshioka H; Yamamoto S; Iida Y; Higuchi T; Oriuchi N; Paudyal B; Paudyal P; Nakamura Y; Endo K
    Ann Nucl Med; 2009 Jul; 23(5):479-85. PubMed ID: 19412654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
    Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
    J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for developing effective radioimmunotherapy for solid tumors.
    DeNardo GL; O'Donnell RT; Kroger LA; Richman CM; Goldstein DS; Shen S; DeNardo SJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3219s-3223s. PubMed ID: 10541367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long duration mild temperature hyperthermia and brachytherapy.
    Armour EP; Raaphorst GP
    Int J Hyperthermia; 2004 Mar; 20(2):175-89. PubMed ID: 15195512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermia: a potent enhancer of radiotherapy.
    Horsman MR; Overgaard J
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):418-26. PubMed ID: 17493790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal origin.
    Aarts F; Koppe MJ; Hendriks T; van Eerd JE; Oyen WJ; Boerman OC; Bleichrodt RP
    Ann Surg Oncol; 2007 Feb; 14(2):533-40. PubMed ID: 17122992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
    J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy and colorectal cancer.
    Koppe MJ; Bleichrodt RP; Oyen WJ; Boerman OC
    Br J Surg; 2005 Mar; 92(3):264-76. PubMed ID: 15739250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different classes of radionuclides for potential use in radioimmunotherapy.
    Karagiannis TC
    Hell J Nucl Med; 2007; 10(2):82-8. PubMed ID: 17684582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy in advanced ovarian cancer: is there a role for pre-targeting with (90)Y-biotin?
    Grana C; Bartolomei M; Handkiewicz D; Rocca P; Bodei L; Colombo N; Chinol M; Mangioni C; Malavasi F; Paganelli G
    Gynecol Oncol; 2004 Jun; 93(3):691-8. PubMed ID: 15196866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Horsman MR
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.
    Aarts F; Bleichrodt RP; de Man B; Lomme R; Boerman OC; Hendriks T
    Ann Surg Oncol; 2008 Nov; 15(11):3299-307. PubMed ID: 18712445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy.
    Dearling JL; Qureshi U; Begent RH; Pedley RB
    Clin Cancer Res; 2007 Mar; 13(6):1903-10. PubMed ID: 17363547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted radionuclide therapy for solid tumors: an overview.
    DeNardo SJ; Denardo GL
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S89-95. PubMed ID: 16979448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.